 |
市场调查报告书
商品编码
1616350
红藤叶萃取物市场机会、成长驱动因素、产业趋势分析和 2024 年至 2032 年预测Red Vine Leaf Extract Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032 |
||||||
2023 年，全球红藤叶萃取物市场价值为 69 亿美元，预计在消费者对其健康益处的认识不断提高的推动下，2024 年至 2032 年复合年增长率为 3.9%。红藤叶萃取物因其丰富的类黄酮和多酚含量而闻名，因其强大的抗发炎和抗氧化特性而备受讚誉。由于技术进步，该行业现在提取了更高品质的红藤叶萃取物，标准化了活性化合物含量。这种增强激起了製药和营养保健品公司的兴趣。
此外，北美和欧洲等地区也收紧了品质控制措施和监管标准。因此，竞争日益激烈，公司将资源投入研发，以符合监管要求和消费者偏好。整个产业分为产品类型、形式、应用、配销通路和地区。 2023 年，红藤叶萃取物粉状市场价值为23 亿美元，预计2024 年至2032 年复合年增长率为4.8%。其配方的多功能性和无缝整合到不同的产品中。
这种粉末形式在将补充剂添加到饮料或冰沙中的消费者中特别受欢迎。红藤叶萃取物市场的膳食补充剂部分到2023 年价值26 亿美元，预计2024 年至2032 年将以4.4% 的复合年增长率增长。特性和心血管支持而备受推崇，使其成为针对老年人和有生活方式相关健康问题的人的首选产品。製药业经常在胶囊和片剂中使用红藤叶萃取物，特别是用于解决慢性静脉功能不全和相关的血管问题。 2023年，北美红藤叶萃取物市场预计将达到19亿美元，预计复合年增长率为4.1%。
| 市场范围 | |
|---|---|
| 开始年份 | 2023年 |
| 预测年份 | 2024-2032 |
| 起始值 | 69 亿美元 |
| 预测值 | 97 亿美元 |
| 复合年增长率 | 3.9% |
北美市场的快速扩张很大程度上归功于人们对天然保健品意识的不断增强以及对预防保健的重视。该地区对营养保健品和膳食补充剂的强劲需求使其成为红藤叶萃取物生产商的主要市场。此外，监管机构，特别是 FDA，在塑造这些市场动态方面发挥关键作用，实施严格的监管以确保产品的安全性和有效性。
目录
第 1 章：方法与范围
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 主要製造商
- 经销商
- 全行业利润率
- 产业影响力
- 成长动力
- 市场挑战
- 市场机会
- 新机会
- 成长潜力分析
- 原料景观
- 製造趋势
- 技术演进
- 永续製造
- 绿色实践
- 脱碳
- 永续製造
- 原材料的可持续性
- 价格趋势（美元/吨），2021 - 2032
- 法规和市场影响
- 波特的分析
- PESTEL分析
第 4 章：竞争格局
- 公司市占率分析
- 竞争定位矩阵
- 战略展望矩阵
第 5 章：市场规模与预测：依产品类型，2021-2032 年
- 主要趋势
- 有机红藤叶萃取物
- 常规红藤叶萃取物
第 6 章：市场规模与预测：按形式划分，2021-2032 年
- 主要趋势
- 粉末
- 液体
- 胶囊
- 平板电脑
第 7 章：市场规模与预测：按应用划分，2021-2032 年
- 主要趋势
- 膳食补充剂
- 药品
- 胶囊和片剂
- 局部应用
- 化妆品及个人护理品
- 食品和饮料
- 其他的
第 8 章：市场规模与预测：按配销通路划分，2021-2032 年
- 主要趋势
- 直销
- 药局和药局
- 健康与保健商店
- 超市/大卖场
- 网路零售
- 其他的
第 9 章：市场规模与预测：按地区划分，2021-2032 年
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 澳洲
- 亚太地区其他地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- MEA
- 沙乌地阿拉伯
- 阿联酋
- 南非
- MEA 的其余部分
第 10 章：公司简介
- Indena SpA
- Hangzhou GreenSky Biological Technology Co., Ltd
- Activ'Inside
- Xi'an Haoze Biotechnology Co., Ltd.
- Croda International Plc
- Actives Ltd
- LAC Global Pte. Ltd.
The Global Red Vine Leaf Extract Market was valued at USD 6.9 billion in 2023, and projections indicate a growth rate of 3.9% CAGR from 2024 to 2032, fueled by heightened consumer awareness of its health benefits. Celebrated for its rich flavonoid and polyphenol content, red vine leaf extract is lauded for its potent anti-inflammatory and antioxidant properties. Thanks to technological advancements, the industry now extracts higher-quality red vine leaf extracts, standardizing active compound levels. This enhancement has piqued the interest of pharmaceutical and nutraceutical companies.
Furthermore, regions like North America and Europe have tightened their quality control measures and regulatory standards. As a result, the landscape has become increasingly competitive, with companies pouring resources into research and development to align with both regulatory mandates and consumer preferences. The overall industry is divided into product type, form, application, distribution channel, and region. In 2023, the powdered segment of the red vine leaf extract market was valued at USD 2.3 billion, with expectations of a 4.8% CAGR from 2024 to 2032. Powdered red vine leaf extract is a mainstay in dietary supplements and functional foods, prized for its versatility in formulations and seamless integration into diverse products.
This powdered form is particularly popular among consumers who incorporate supplements into drinks or smoothies. Valued at USD 2.6 billion in 2023, the dietary supplements segment of the red vine leaf extract market is projected to grow at a 4.4% CAGR from 2024 to 2032. Within dietary supplements, the extract is prized for its circulation-boosting properties and cardiovascular support, making it a preferred choice for products targeting older adults and those with lifestyle-related health issues. The pharmaceutical industry often utilizes red vine leaf extract in capsules and tablets, especially for addressing chronic venous insufficiency and related vascular concerns. In 2023, North America red vine leaf extract market is projected to reach USD 1.9 billion, with an anticipated growth rate of 4.1% CAGR.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $6.9 Billion |
| Forecast Value | $9.7 Billion |
| CAGR | 3.9% |
The swift expansion of North America market is largely attributed to a growing awareness of natural health products and a strong emphasis on preventive healthcare. The region's strong demand for nutraceuticals and dietary supplements makes it a key market for red vine leaf extract producers. Moreover, regulatory bodies, especially the FDA, play a pivotal role in shaping these market dynamics, imposing strict regulations to ensure product safety and efficacy.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Forecast calculation
- 1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
- 1.4.2.1 Paid sources
- 1.4.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Key manufacturers
- 3.1.2 Distributors
- 3.1.3 Profit margins across the industry
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Market challenges
- 3.2.3 Market opportunity
- 3.2.3.1 New opportunities
- 3.2.3.2 Growth potential analysis
- 3.3 Raw material landscape
- 3.3.1 Manufacturing trends
- 3.3.2 Technology evolution
- 3.3.2.1 Sustainable manufacturing
- 3.3.2.1.1 Green practices
- 3.3.2.1.2 Decarbonization
- 3.3.2.1 Sustainable manufacturing
- 3.3.3 Sustainability in raw materials
- 3.3.4 Pricing trends (USD/Ton), 2021 - 2032
- 3.3.4.1 North America
- 3.3.4.2 Europe
- 3.3.4.3 Asia Pacific
- 3.3.4.4 Latin America
- 3.3.4.5 Middle East & Africa
- 3.4 Regulations & market impact
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Company market share analysis
- 4.2 Competitive positioning matrix
- 4.3 Strategic outlook matrix
Chapter 5 Market Size and Forecast, By Product Type, 2021-2032 (USD Billion, Tons)
- 5.1 Key trends
- 5.2 Organic red vine leaf extract
- 5.3 Conventional red vine leaf extract
Chapter 6 Market Size and Forecast, By Form, 2021-2032 (USD Billion, Tons)
- 6.1 Key trends
- 6.2 Powder
- 6.3 Liquid
- 6.4 Capsules
- 6.5 Tablets
Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Billion, Tons)
- 7.1 Key trends
- 7.2 Dietary Supplements
- 7.3 Pharmaceuticals
- 7.3.1 Capsules & Tablets
- 7.3.2 Topical Applications
- 7.4 Cosmetics & Personal Care
- 7.5 Food & Beverages
- 7.6 Others
Chapter 8 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Billion, Tons)
- 8.1 Key trends
- 8.2 Direct Sales
- 8.3 Pharmacies & Drugstores
- 8.4 Health & Wellness Stores
- 8.5 Supermarkets/Hypermarkets
- 8.6 Online Retail
- 8.7 Others
Chapter 9 Market Size and Forecast, By Region, 2021-2032 (USD Billion, Tons)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Australia
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 MEA
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 South Africa
- 9.6.4 Rest of MEA
Chapter 10 Company Profiles
- 10.1 Indena S.p.A.
- 10.2 Hangzhou GreenSky Biological Technology Co., Ltd
- 10.3 Activ'Inside
- 10.4 Xi'an Haoze Biotechnology Co., Ltd.
- 10.5 Croda International Plc
- 10.6 Actives Ltd
- 10.7 LAC Global Pte. Ltd.
